Growth Metrics

Cytosorbents (CTSO) EBIT Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -20.56%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 11.83%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -11.06%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 19.54%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 20.97%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 74.18%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 90.95%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -18.12%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 46.60%
10 Cytosorbents 28.81 Mn 24.01 Mn 6.13 Mn 21.71%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 21.71%
Dec 31, 2025 -29.16%
Sep 30, 2025 40.75%
Jun 30, 2025 -1.26%
Mar 31, 2025 16.50%
Dec 31, 2024 63.91%
Sep 30, 2024 34.29%
Jun 30, 2024 45.57%
Mar 31, 2024 41.00%
Dec 31, 2023 -48.01%
Sep 30, 2023 18.49%
Jun 30, 2023 21.51%
Mar 31, 2023 -1.29%
Dec 31, 2022 33.52%
Sep 30, 2022 -66.80%
Jun 30, 2022 -69.70%
Mar 31, 2022 -173.16%
Dec 31, 2021 -262.98%
Sep 30, 2021 -175.87%
Jun 30, 2021 -49.34%
Mar 31, 2021 -15.07%
Dec 31, 2020 51.50%
Sep 30, 2020 65.18%
Jun 30, 2020 9.16%
Mar 31, 2020 42.16%
Dec 31, 2019 2.76%
Sep 30, 2019 -107.61%
Jun 30, 2019 13.32%
Mar 31, 2019 -38.18%
Dec 31, 2018 -46.78%
Sep 30, 2018 -26.13%
Jun 30, 2018 -79.67%
Mar 31, 2018 -99.11%
Dec 31, 2017 16.74%
Sep 30, 2017 -0.23%
Jun 30, 2017 13.26%
Mar 31, 2017 25.48%
Dec 31, 2016 -106.41%
Sep 30, 2016 0.28%
Jun 30, 2016 -20.65%
Mar 31, 2016 22.92%
Dec 31, 2015 23.43%
Sep 30, 2015 -44.94%
Jun 30, 2015 -63.38%
Mar 31, 2015 -134.94%
Dec 31, 2014 -187.93%
Sep 30, 2014 -68.62%
Jun 30, 2014 3.09%
Mar 31, 2014 18.85%
Dec 31, 2013 -23.54%
Sep 30, 2013 -46.35%
Jun 30, 2013 -39.36%
Mar 31, 2013 -33.26%
Dec 31, 2012 16.06%
Sep 30, 2012 50.95%
Jun 30, 2012 9.39%
Mar 31, 2012 5.43%
Dec 31, 2011 -103.84%
Sep 30, 2011 -55.46%
Jun 30, 2011 -64.75%